US Stock MarketDetailed Quotes
NBRVF Nabriva Therapeutics PLC
- 0.000
- +0.000+9900.00%
15min DelayClose Nov 29 13:00 ET
323.08Market Cap0.00P/E (TTM)
0.000High0.000Low500Volume0.000Open0.000Pre Close0.05Turnover0.02%Turnover Ratio0.00P/E (Static)3.23MShares0.52452wk High0.00P/B321.88Float Cap0.00052wk Low--Dividend TTM3.22MShs Float4370.000Historical High--Div YieldTTM0.00%Amplitude0.000Historical Low0.000Avg Price1Lot Size
About Nabriva Therapeutics PLC Company
Nabriva Therapeutics Plc is a biopharmaceutical company, which engages in the commercialization and development of novel anti-infective agents to treat infections. The company was founded in October 2005 and is headquartered in Dublin, Ireland.
Company Profile
SymbolNBRVF
Company NameNabriva Therapeutics PLC
Listing DateSep 18, 2015
Founded2017
CEOMr. H. Michael Hogan
MarketPink Market
Employees39
Fiscal Year Ends12-31
Address25-28 North Wall Quay,IFSC
CityDublin
ProvinceDublin
CountryIreland
Zip Code1
Phone353-1-649-2000
Websitehttp://www.nabriva.com
Company Executives
- Name
- Position
- Salary
- H. Michael Hogan
- Chief Executive Officer
- --
- Dave Maggio
- Chief Financial Officer
- --
- Daniel Dolan
- Chief Financial Officer and Principal Accounting Officer
- --
- Daniel D. Burgess
- Chairman of the Board
- --
- Theodore R. Schroeder
- Director
- --
- Dr. Steven P. Gelone,Pharm.D.
- Director
- --
- Charles A. Rowland, M.B.A.
- Independent Director
- --
- Stephen W. Webster
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
